Literature DB >> 15637396

Nutritional interventions in cancer prevention.

Philip R Taylor1, Peter Greenwald.   

Abstract

The first generation of phase III nutritional intervention studies to prevent cancer has been completed. Nearly 150,000 total participants were studied in nine different interventions using randomized, double-blind, placebo-controlled designs that tested whether vitamins and/or minerals, given singly or in combination, could prevent total or site-specific cancer. The primary agents tested include beta-carotene, alpha-tocopherol, selenium, and retinol. This review summarizes the findings from the first generation of human experimental studies that tested micronutrients in the prevention of cancer, discusses lessons learned from these studies, identifies the most promising leads, and describes future prospects in nutritional intervention research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637396     DOI: 10.1200/JCO.2005.06.190

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  14 in total

1.  Targeting CWR22Rv1 prostate cancer cell proliferation and gene expression by combinations of the phytochemicals EGCG, genistein and quercetin.

Authors:  Tze-Chen Hsieh; Joseph M Wu
Journal:  Anticancer Res       Date:  2009-10       Impact factor: 2.480

Review 2.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

3.  Selenoglycoproteins attenuate adhesion of tumor cells to the brain microvascular endothelium via a process involving NF-κB activation.

Authors:  Jagoda K Wrobel; Jeong June Choi; Rijin Xiao; Sung Yong Eum; Stefan Kwiatkowski; Gretchen Wolff; Leya Spangler; Ronan F Power; Michal Toborek
Journal:  J Nutr Biochem       Date:  2014-10-28       Impact factor: 6.048

Review 4.  Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements.

Authors:  Jolanta Gromadzińska; Edyta Reszka; Katharina Bruzelius; Wojciech Wasowicz; Björn Akesson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

5.  Vitamin E delta-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration.

Authors:  Kazim Husain; Rony A Francois; Sean Z Hutchinson; Anthony M Neuger; Richard Lush; Domenico Coppola; Said Sebti; Mokenge P Malafa
Journal:  Pharmacology       Date:  2009-01-13       Impact factor: 2.547

Review 6.  Toward understanding success and failures in the use of selenium for cancer prevention.

Authors:  Holger Steinbrenner; Bodo Speckmann; Helmut Sies
Journal:  Antioxid Redox Signal       Date:  2013-03-21       Impact factor: 8.401

7.  Vitamin E δ-tocotrienol prolongs survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) transgenic mouse model of pancreatic cancer.

Authors:  Kazim Husain; Barbara A Centeno; Dung-Tsa Chen; Sunil R Hingorani; Said M Sebti; Mokenge P Malafa
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-20

8.  The balance between food and dietary supplements in the general population.

Authors:  Marleen A H Lentjes
Journal:  Proc Nutr Soc       Date:  2018-10-30       Impact factor: 6.297

9.  Vitamin and mineral supplements: do we really need them?

Authors:  Farin Kamangar; Ashkan Emadi
Journal:  Int J Prev Med       Date:  2012-03

10.  Poly-γ-glutamic acid induces apoptosis via reduction of COX-2 expression in TPA-induced HT-29 human colorectal cancer cells.

Authors:  Eun Ju Shin; Mi Jeong Sung; Jae Ho Park; Hye Jeong Yang; Myung Sunny Kim; Haeng Jeon Hur; Jin-Taek Hwang
Journal:  Int J Mol Sci       Date:  2015-04-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.